High platelets, a condition called thrombocytosis, means your blood contains more than 450,000 platelets per microliter. A normal range falls between 150,000 and 450,000. In most cases, elevated platelets are a temporary reaction to something else happening in your body, like an infection, inflammation, or iron deficiency. Less commonly, a bone marrow disorder is producing too many platelets on its own.
Understanding which type you’re dealing with matters because the causes, risks, and next steps are quite different.
Reactive vs. Primary Thrombocytosis
Doctors split high platelet counts into two broad categories. Reactive (or secondary) thrombocytosis is by far the more common one. Here, your platelets rise in response to another condition, and they typically come back down once that condition is treated or resolves. The platelets themselves function normally, and the risk of dangerous clotting is low.
Primary thrombocytosis means your bone marrow is overproducing platelets because of a genetic change in blood-forming cells. The most well-known form is essential thrombocythemia, which affects roughly 0.2 to 2.7 people per 100,000 each year. Other bone marrow disorders, including polycythemia vera and primary myelofibrosis, can also push platelet counts up. In primary thrombocytosis, platelet counts tend to run higher on average (around 800,000) compared to reactive causes (around 562,000), and the risk of blood clots is more significant.
Common Reactive Causes
The list of things that can temporarily raise your platelet count is long, but a few stand out as the most frequent triggers.
Infections: Both acute and chronic infections stimulate platelet production as part of your body’s broader inflammatory response. Bacterial infections are a particularly common culprit, though viral infections can do it too. Tuberculosis and other chronic infections are well-established causes.
Chronic inflammatory conditions: Rheumatoid arthritis, inflammatory bowel disease, sarcoidosis, and similar conditions keep your immune system in a state of ongoing activation. That sustained inflammation signals your bone marrow to make more platelets. In one study comparing reactive and primary thrombocytosis, about 12% of people with reactive high platelets had a chronic inflammatory disease.
Iron deficiency: This is one of the most overlooked causes. When your body is low on iron, it directly changes how platelet-producing cells in the bone marrow behave. Iron deficiency pushes more stem cells toward becoming platelet-makers and accelerates their maturation. Interestingly, this happens without any change in thrombopoietin, the hormone that normally regulates platelet production. It’s a direct effect of low iron on the bone marrow itself. About 16% of people with reactive thrombocytosis in one large cohort had iron deficiency anemia.
Surgery and spleen removal: Any major surgery can cause a temporary platelet spike as part of the healing response. Spleen removal (splenectomy) is a special case because the spleen normally stores about one-third of your platelets. Without it, those platelets stay in circulation, and counts rise. This elevation typically becomes apparent in the first few days after surgery and can persist for weeks.
Bleeding: Significant blood loss, whether from an injury, surgery, or gastrointestinal bleeding, triggers your bone marrow to ramp up production of all blood cells, including platelets.
Cancer as a Cause
Solid tumors can raise platelet counts even when the cancer has nothing to do with the bone marrow. This is called paraneoplastic thrombocytosis. Tumors release signaling molecules, particularly one called interleukin-6, that stimulate platelet production. Cancers of the lung, ovary, stomach, colon, kidney, and breast are the types most commonly linked to this effect.
The prevalence varies by cancer type. In ovarian cancer, about 31% of newly diagnosed patients have elevated platelets. In lung cancer, studies have found rates between 16% and 32%. Colorectal cancer ranges widely depending on the threshold used, from about 12% to nearly 50%. Thrombocytosis at the time of a cancer diagnosis is consistently linked to worse outcomes across tumor types, which is why doctors pay attention to unexplained high platelet counts that don’t have an obvious reactive cause.
Genetic Causes and Essential Thrombocythemia
When the bone marrow itself is the problem, specific genetic mutations are usually driving the overproduction. In essential thrombocythemia, about 62% of patients carry a mutation in a gene called JAK2, which acts like a stuck “on” switch for cell growth. Another 11 to 31% have mutations in a gene called CALR, and 2 to 5% have mutations in a gene called MPL, which affects the receptor that tells your bone marrow to make platelets.
A small percentage of patients, roughly 23% in one large cohort, have none of these known mutations. Essential thrombocythemia tends to be diagnosed at an older age, with an average around 69 years, compared to about 56 for reactive causes. People with the primary form are also more likely to have a history of arterial blood clots, which can be an early clue pointing toward a bone marrow disorder rather than a reactive cause.
Symptoms of High Platelets
Mildly elevated platelets from reactive causes rarely produce symptoms on their own. You’ll feel whatever the underlying condition is causing, whether that’s joint pain from arthritis or fatigue from iron deficiency, but the platelets themselves are typically silent.
Primary thrombocytosis is a different story. The most significant risk is abnormal blood clotting. Clots can form in arteries supplying the brain, causing strokes or mini-strokes (transient ischemic attacks). They can develop in leg veins, causing pain and swelling, or travel to the lungs, leading to chest pain and shortness of breath. Some people experience headaches, weakness, or an enlarged spleen.
One distinctive symptom is erythromelalgia: episodes of intense burning pain, redness, and swelling, most often in the hands and feet. Tingling or prickling sensations in the skin can also occur. Counterintuitively, people with very high platelet counts (often above 1 million) can actually develop bleeding problems rather than clotting, with nosebleeds, bleeding gums, or gastrointestinal bleeding.
How Doctors Determine the Cause
The first step is usually figuring out whether an obvious reactive trigger exists. Your doctor will look at your full blood count, check for signs of infection or inflammation, and test your iron levels. Smoking history matters too, as smoking is associated with reactive thrombocytosis.
Several clues in routine blood work help distinguish reactive from primary causes. Reactive thrombocytosis tends to come with higher white blood cell counts and lower hemoglobin, reflecting the underlying infection or inflammation. Primary thrombocytosis tends to show higher hemoglobin, larger red blood cells, and larger platelets on average.
If no reactive cause is found, genetic testing for JAK2, CALR, and MPL mutations is the next step. A bone marrow biopsy may also be performed to look at how platelet-producing cells are behaving. In primary thrombocytosis, these cells are often larger and more mature than normal.
How High Platelets Are Managed
For reactive thrombocytosis, treatment is straightforward: address whatever is causing the elevation. Treat the infection, manage the inflammatory condition, or correct the iron deficiency, and platelet counts generally return to normal on their own. Specific platelet-lowering treatment is rarely needed.
For essential thrombocythemia, management depends on your risk of clotting and how high counts run. There’s no single agreed-upon target, but many specialists aim to keep counts below 400,000 to 600,000. When counts climb above 1 million, the risk profile shifts, and treatment becomes more urgent. Low-dose aspirin is commonly used to reduce clotting risk, and platelet-lowering medications are added for higher-risk patients. The goal is preventing clots and bleeding while keeping side effects manageable, and most people with essential thrombocythemia live normal or near-normal lifespans with appropriate monitoring.